Barrett & Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Hold
2,152
– – 0.05% 162
2026
Q2
$197K Hold
2,152
– – 0.06% 168
2026
Q1
$183K Hold
2,152
– – 0.06% 159
2025
Q4
$170K Hold
2,152
– – 0.06% 169
2025
Q3
$172K Hold
2,152
– – 0.06% 164
2025
Q2
$196K Buy
2,152
+1,852
+617% +$169K 0.07% 147
2025
Q1
$28.1K Hold
300
– – 0.01% 339
2024
Q4
$27.3K Hold
300
– – 0.01% 344
2024
Q3
$31.1K Hold
300
– – 0.01% 319
2024
Q2
$29.1K Hold
300
– – 0.01% 328
2024
Q1
$27K Hold
300
– – 0.01% 338
2023
Q4
$23.9K Hold
300
– – 0.01% 324
2023
Q3
$21.3K Hold
300
– – 0.01% 332
2023
Q2
$23.1K Buy
+300
New +$23.2K 0.01% 333

Other funds holding CL

Barrett & Company's CL Position: Q3 2026 in Review

Barrett & Company held its Colgate-Palmolive (CL) position steady in Q3 2026 at 2,152 shares worth $184K. The position accounts for 0.05% of the portfolio, ranked #162.

Barrett & Company first reported a position in CL in Q2 2023 and has held it in 14 quarters since. The position peaked at $197K in Q2 2026. 647 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Barrett & Company held 2,152 shares of Colgate-Palmolive worth $184K as of Q3 2026.
  • Barrett & Company left its Colgate-Palmolive share count unchanged in Q3 2026.
  • Colgate-Palmolive made up 0.05% of Barrett & Company's portfolio in Q3 2026, its #162 holding.
  • Barrett & Company first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 14 quarters since.
  • Barrett & Company's Colgate-Palmolive position peaked at $197K in Q2 2026.
  • 647 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.